What Creative Diagnostics does

Creative Diagnostics is a privately held New York-based biotechnology company founded in 2005 that manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, hybridomas, and related reagents to life science research and in vitro diagnostics (IVD) customers. The company serves pharmaceutical and biotechnology firms, IVD manufacturers, academic research institutions, food safety laboratories, and veterinary diagnostic organizations across more than 40 countries, with contact offices in the United States (Long Island, NY) and the United Kingdom (Manchester).

The product and technology stack centers on antibody and antigen development built around proprietary platforms including Magic Hybridoma™, Omni-Hybridoma™, and MPAT™ for antibody discovery, the HiResNb™/VHH nanobody platform, the MemND™ nanodisc system for membrane protein research, and the Magic™ adjuvant family. Creative Diagnostics maintains a catalog exceeding 80,000 primary antibodies across more than 14,000 targets, complemented by a services portfolio spanning antigen generation, custom antibody production (monoclonal, polyclonal, VHH, anti-idiotype, phospho-specific), contract assay development (ELISA, lateral flow, chemiluminescent immunoassay), immunocytochemistry, analytical services (anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization, ADC PK assays), immunoprecipitation, and subcellular fractions for ADME studies. Most recent capability additions include an AI-assisted protein engineering service and an integrated AI-powered CRO platform for infectious disease drug discovery launched in February 2026.

Revenue is generated through three channels — catalog reagent sales, custom development and analytical services, and IVD raw material supply — all conducted on a quote-based pricing model with sales inquiries responded to within 24 hours. Go-to-market combines direct sales through the company's e-commerce inquiry platform, a global distributor network, and event-driven engagement at major industry conferences (MEDICA, ADLM, ASM Microbe). The company is consistently launching new products: 2024 saw Rapid Robenidine Test Reagents for poultry food safety; 2025 brought VHH reagents for swine disease, ADME/Renal Metabolism lines, dengue virus mouse models, Respiratory Syncytial Virus Antigens, and the CDJCV™ Anti-polyomavirus JC IgG ELISA Kit; 2026 has added the AI-powered CRO platform, subcellular fractions for renal metabolism, and equine disease detection reagents. The company is recognized as a top-five player in the chloramphenicol test kits market and operates without disclosed venture capital or private equity backing.

Name

Creative Diagnostics

Legal name

Creative Diagnostics

Website

https://creative-diagnostics.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

Creative Diagnostics is a privately held New York-based biotech company that manufactures antibodies, antigens, ELISA kits, rapid test kits, and custom assay services for pharmaceutical, IVD, academic, veterinary, and food safety customers across more than 40 countries.

Ownership category

akta.pro rank

Product category

Life Science Reagents and Diagnostic Antibodies

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Scientific Research and Development Services (5417)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

Keywords

• Antibody manufacturing
• Antigen reagents
• ELISA kits
• Custom antibody development
• In vitro diagnostics

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Research-use Antibodies and Antigens: Sale of research-use antibodies, antigens, ELISA kits, and reagents to pharmaceutical companies, biotechnology companies, diagnostic manufacturers, and academic research institutions worldwide.
2. Custom Services: Contract research services including custom antibody development, assay development, and analytical services for drug discovery and development.
3. IVD Raw Materials: Supply of immunodiagnostic raw materials including high-quality antibodies and antigens for assay development to IVD and life science companies.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels4 records

Core offering

Creative Diagnostics manufactures and supplies antibodies, antigens, ELISA kits, rapid test kits, and hybridoma cell lines for life science research and in vitro diagnostics. It also operates a custom services arm covering antigen generation, antibody generation (including VHH/nanobodies and DNA/LNP-mRNA platforms), contract assay development (ELISA, CLIA, lateral flow), immunocytochemistry, analytical bioanalytical services, and immunoprecipitation services, supported by an AI-powered integrated CRO platform for infectious disease drug discovery.

Product overview

Creative Diagnostics is a New York-based manufacturer and supplier of antibodies, antigens, and assay kits for the IVD and life science communities. The product portfolio centers on immunoassay reagents organized around core product categories: Antibodies (primary, secondary, and control antibodies including monoclonal, polyclonal, and recombinant formats), Antigens (viral, bacterial, fungal, parasitic antigens, synthetic peptides, and VLP-displayed antigens), ELISA Kits (autoimmune, cardiac, cytokine, food safety, infectious disease, hormone, and tumor marker kits), Rapid Test Kits, Materials and Reagents (adjuvants, conjugation kits, ECL substrates), and Hybridomas. The portfolio includes branded products such as Magic™ Adjuvant, HiResNb™ Secondary VHH Antibodies, and CDSimple™ Chemiluminescent ELISA Kits. Services are organized as a separate offerings layer covering Antigen Generation, Antibody Generation (including VHH production), Contract Assay Development, Immunocytochemistry, Analytical Services, and Immunoprecipitation Services. Technical platforms support both Antibody Discovery & Development (B Cell Sorting, Hybridoma platforms, MPAT™) and IVD assay development (CLIA, LFIA, ELISA). The company also offers an AI-powered integrated CRO platform for infectious disease drug discovery.

Differentiator

Problem solved

Functional benefit

Brands

• HiResNb™: Nano secondary antibodies (Nanobodies/VHHs) for research applications, including recombinant alpaca anti-Rabbit and anti-Mouse IgG antibodies with various conjugates
• CDSimple™
• Magic™
• RapidGet™
• CDJCV™
• RHA™
• MemND™
• Magic Hybridoma™
• Omni-Hybridoma™
• MPAT™

Products and services

• Antibodies (Primary, Secondary, Control) High-quality antibodies including monoclonal, polyclonal, and recombinant primary antibodies (80,000+ against 14,000+ targets), species-specific secondary antibodies with various conjugated labels, and control antibodies (anti-Tubulin, GAPDH, β-Actin, Histone H3) for Western blot, immunoprecipitation, immunofluorescence, and ELISA; sold to research and IVD laboratories.
• Antigens (Viral, Bacterial, Fungal, Parasitic) Catalog of viral, bacterial, fungal, and parasitic antigens, plus synthetic peptides, blocking peptides, recombinant proteins, VLP-displayed antigens, autoantigens, cytokines and hormones antigens, cancer biomarker antigens, cardiac biomarkers, allergens, and neurodegeneration antigens; used by vaccine, immunology, and infectious disease researchers.
• ELISA Kits ELISA kits covering autoimmune, cardiac markers, cytokines, food safety, infectious disease, hormone markers, tumor markers, and specialty analytes, including high-sensitivity chemiluminescent CDSimple™ kits; sold to clinical, food safety, and research laboratories.
• Rapid Test Kits Point-of-care rapid diagnostic test kits for applications including food safety (e.g., chloramphenicol residue testing, Rapid Robenidine Test Reagents for poultry) and infectious disease screening; sold to food testing laboratories and veterinary/poultry diagnostics customers.
• Materials and Reagents (including Magic™ Adjuvant, ECL substrates, conjugation kits) Adjuvants (Magic™ Adjuvant, Magic™ Camelid Adjuvant), antibody conjugation kits, ECL substrates, Magic-Fluor™ mIHC Staining Kits, cell freezing media, antibody isotyping kits, recombinant virus protein test kits, lentivirus titer kits, N-glycan analysis kits, and active pre-formed fibrils; sold as ancillary reagents to antibody and assay development laboratories.
• Hybridomas Hybridoma cell lines (mouse, rat, hamster, and heterohybridoma) used to produce monoclonal antibodies, including IHC-positive screening services; supplied to research and industrial antibody production customers.
• Antigen Generation Services Custom antigen generation services covering protein antigen expression, peptide antigen synthesis and conjugation, antigen retrieval services, the MemND™ Nanodisc system for membrane protein antigens, AI-assisted protein engineering, and Avi-tag site-specific biotinylation; performed for pharma, biotech, and academic clients.
• Antibody Generation Services Custom antibody development services including monoclonal, polyclonal, anti-idiotype, anti-hapten, transmembrane, phospho-specific, VHH/nanobody, DNA immunization, LNP-mRNA-based, RIMMS, and Quenchbody antibody production, plus antibody modification (labeling, fragmentation, purification, hybridoma optimization, scale-up); provided to pharma, biotech, and academic customers.
• Contract Assay Development Contract development of ELISA kits, colloidal gold lateral flow strips, chemiluminescent immunoassays, virus-like particle antigens, and pharmaceutical/diagnostic testing platforms (allergen and autoimmune disease analysis); offered to IVD manufacturers and research customers.
• Analytical Services Bioanalytical services for biologics and vaccine development, including anti-drug antibody assays, epitope mapping, biomolecular interaction analysis, SARS-CoV-2 pseudovirus neutralization and ADE assays, PK assays for ADCs, and custom cellular biosensors for ligand-receptor interaction studies; supplied to pharma and biotech developers.
• Immunoprecipitation Services Immunoprecipitation services including Co-IP/MS, tandem affinity purification/MS (TAP/MS), chromatin immunoprecipitation (ChIP), RNA immunoprecipitation (RIP), cross-linking and immunoprecipitation (CLIP), and standard IP; provided to academic and industry research groups studying protein interactions and chromatin.
• Equine Diseases Detection Reagents Reagents for detecting equine infectious anemia virus (EIAV), equine influenza virus (EIV), and equine arteritis virus (EAV) in horses, validated for ELISA, Western blotting, and immunofluorescence assays; targeted at veterinary diagnostics and equine surveillance laboratories.
• Products for Renal Metabolism Subcellular fractions (kidney microsomes and cytosol) from human, non-human primate, beagle dog, minipig, and rodent species, used by pharmaceutical researchers and toxicologists for in vitro drug metabolism and ADME studies.
• Integrated CRO Platform for AI-Powered Infectious Disease Drug Discovery AI-powered integrated CRO service platform that combines molecular modeling, virtual screening, and data analysis to help biotech and pharmaceutical researchers identify lead compounds for infectious diseases faster than conventional methods, from target identification through candidate optimization.
• CDJCV™ Anti-polyomavirus JC IgG ELISA Kit ELISA kit for detecting JC polyomavirus IgG antibodies in human serum, intended to aid research into JCV-related diseases including progressive multifocal leukoencephalopathy (PML); targeted at clinical and translational research laboratories.
• VHH Reagents and Antigens for Swine Disease Detection VHH (nanobody) reagents and antigens for rapid diagnosis of porcine reproductive and respiratory syndrome virus (PRRSV) and related swine viruses, supporting competitive ELISAs and immunofluorescence tests; targeted at veterinary and livestock diagnostics laboratories.
• Respiratory Syncytial Virus Antigens Antigen product line covering key Respiratory Syncytial Virus proteins from subgroups A and B, used in RSV diagnostics, vaccine development, and virological studies by research and vaccine developer customers.
• Dengue Virus Mouse Models Validated mouse models for dengue virus (DENV) research that mimic human infection symptoms and immune responses, used to study DENV pathogenesis and develop antiviral drugs and vaccines across multiple serotypes and strains.

Quantifiable outcome

• Reduces antibody development time through proprietary Magic™ Adjuvant formulation requiring fewer immunizations and less antigen dosage
• +1 more outcomes

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Partnerships

One partnership is on record.

• Market Report Publisher (Market Research Company)minorOthersCreative Diagnostics is identified as a top company in the Hantavirus Diagnostics Market (2026-2033) in a market research report, indicating recognition within the industry analyst community.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• GenScript: GenScript is a direct competitor offering custom antibody development, recombinant antibody production, and an extensive catalog of research-use antibodies — directly overlapping Creative Diagnostics' core custom services and catalog business across pharma/biotech and academic customers.
• Abcam (Danaher): Abcam is the largest catalog antibody supplier globally with over 100,000 products targeting similar applications (WB, ELISA, IHC, FC). It is a primary direct competitor to Creative Diagnostics in the same research-use antibody and reagent category serving the same pharma/biotech/academic customer base.
• Cell Signaling Technology: Cell Signaling Technology offers high-validity antibodies (especially phospho-specific and signaling-pathway targets) with strong validation data — directly competing with Creative Diagnostics' catalog in research antibody applications and overlapping on cancer and cell biology research areas.
• Novus Biologicals (Bio-Techne): Novus Biologicals, part of Bio-Techne, is a direct competitor supplying primary antibodies, ELISA kits, and reagents to the same life science research customer base, with comparable catalog breadth across thousands of targets.
• Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established research antibody supplier offering monoclonal and polyclonal antibodies across broad research applications, directly competing with Creative Diagnostics' catalog antibodies in academic and pharma research markets.
• Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies, ELISA kits, and immunochemical reagents with custom antibody services, directly overlapping Creative Diagnostics' custom antibody production and catalog reagent offering for research and IVD customers.
• ProSci Incorporated: ProSci is a specialty custom antibody and immunoassay service provider offering polyclonal, monoclonal, and affinity purification services — directly comparable to Creative Diagnostics' custom antibody development, analytical, and immunoprecipitation service offerings.
• Jackson ImmunoResearch: Jackson ImmunoResearch specializes in secondary antibodies and antibody conjugates used in life science research — directly comparable to Creative Diagnostics' secondary antibody portfolio including the HiResNb™ VHH nano-secondary line.

Broad incumbents

• Bio-Rad Laboratories: Bio-Rad is a broad life-science tools incumbent offering antibodies, ELISA kits, protein electrophoresis, and clinical diagnostics products across its portfolio — overlapping Creative Diagnostics' catalog reagents and IVD-adjacent offerings but as one of many product lines.
• PerkinElmer (Revvity): PerkinElmer/Revvity is a broad incumbent in life sciences and diagnostics with companion food-safety testing capabilities — listed alongside Creative Diagnostics as a top 5 player in the chloramphenicol test kits market and active in similar IVD assay reagent categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/winsletkerry
• Facebookfacebook.com/CreativeDiagnostics
• LinkedInlinkedin.com/company/creative-daignostics

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Creative Diagnostics